Published in Neurotherapeutics on January 01, 2010
The role of markers of inflammation in traumatic brain injury. Front Neurol (2013) 2.01
Traumatic brain injury. Philos Trans R Soc Lond B Biol Sci (2011) 1.29
Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here? Br J Pharmacol (2011) 1.28
Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation (2010) 1.23
Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery (2012) 1.14
Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J Neurotrauma (2012) 1.10
Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. J Neurotrauma (2012) 1.09
Cognitive sequelae of blast-induced traumatic brain injury: recovery and rehabilitation. Neuropsychol Rev (2012) 1.06
MicroRNA let-7i is a promising serum biomarker for blast-induced traumatic brain injury. J Neurotrauma (2012) 1.02
Can structural or functional changes following traumatic brain injury in the rat predict epileptic outcome? Epilepsia (2013) 0.98
Analysis of functional pathways altered after mild traumatic brain injury. J Neurotrauma (2013) 0.96
Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury. Brain Behav Immun (2014) 0.95
S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. J Neurotrauma (2013) 0.92
Systems biology approaches for discovering biomarkers for traumatic brain injury. J Neurotrauma (2013) 0.92
Application of blood-based biomarkers in human mild traumatic brain injury. Front Neurol (2013) 0.90
Combining biochemical and imaging markers to improve diagnosis and characterization of mild traumatic brain injury in the acute setting: results from a pilot study. PLoS One (2013) 0.86
New astroglial injury-defined biomarkers for neurotrauma assessment. J Cereb Blood Flow Metab (2017) 0.85
Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury. J Neurotrauma (2010) 0.84
The diagnosis of traumatic brain injury on the battlefield. Front Neurol (2012) 0.83
A computational pipeline for the development of multi-marker bio-signature panels and ensemble classifiers. BMC Bioinformatics (2012) 0.82
Current status of fluid biomarkers in mild traumatic brain injury. Exp Neurol (2015) 0.82
Targeted Lipid Profiling Discovers Plasma Biomarkers of Acute Brain Injury. PLoS One (2015) 0.80
Role and Importance of IGF-1 in Traumatic Brain Injuries. Biomed Res Int (2015) 0.77
The visual effects of intraocular colored filters. Scientifica (Cairo) (2012) 0.77
Epilepsy related to traumatic brain injury. Neurotherapeutics (2014) 0.77
Fluid biomarkers for mild traumatic brain injury and related conditions. Nat Rev Neurol (2016) 0.77
The influence of BMX gene polymorphisms on clinical symptoms after mild traumatic brain injury. Biomed Res Int (2014) 0.76
Molecular biomarkers of epileptogenesis. Neurotherapeutics (2014) 0.76
Use of Tethered Enzymes as a Platform Technology for Rapid Analyte Detection. PLoS One (2015) 0.75
The anti-inflammatory properties of Satureja khuzistanica Jamzad essential oil attenuate the effects of traumatic brain injuries in rats. Sci Rep (2016) 0.75
Phage display for identification of serum biomarkers of traumatic brain injury. J Neurosci Methods (2016) 0.75
Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest. Biosensors (Basel) (2017) 0.75
Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med (2004) 16.53
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci (1992) 11.73
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med (2008) 7.33
Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci (2002) 5.45
Traumatic brain injury in the war zone. N Engl J Med (2005) 5.08
High serum S100B levels for trauma patients without head injuries. Neurosurgery (2001) 4.16
Cytokines and acute neurodegeneration. Nat Rev Neurosci (2001) 3.70
A population-based study of seizures after traumatic brain injuries. N Engl J Med (1998) 3.12
Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem (2002) 3.05
Isoprostanes: markers and mediators of oxidative stress. FASEB J (2004) 2.83
Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat Biotechnol (2006) 2.66
Ceruloplasmin metabolism and function. Annu Rev Nutr (2002) 2.52
Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care (2002) 2.48
Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit Care Med (2010) 2.44
Interleukin-1 stimulation of astroglial proliferation after brain injury. Science (1985) 2.35
Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res (1996) 2.24
Oxidative alterations in Alzheimer's disease. Brain Pathol (1999) 2.21
4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev (2008) 2.02
Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J Neurosurg (2005) 1.99
Serum creatine kinase isoenzyme BB is a poor index to the size of various brain lesions. Clin Chem (1989) 1.99
Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology (2004) 1.97
Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol (2001) 1.91
Attention, learning, and memory performances and intellectual resources in Vietnam veterans: PTSD and no disorder comparisons. Neuropsychology (2002) 1.88
Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J Cereb Blood Flow Metab (2006) 1.86
Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J Neurochem (2009) 1.85
Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res (1989) 1.81
Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: a meta-analysis. J Affect Disord (2005) 1.80
TGF-beta receptors and actions. Biochim Biophys Acta (1994) 1.78
Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock (2001) 1.77
Therapeutic hypothermia preserves antioxidant defenses after severe traumatic brain injury in infants and children. Crit Care Med (2009) 1.70
GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma (2004) 1.65
Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp Neurol (2006) 1.63
Developing an agenda for translational studies of resilience and vulnerability following trauma exposure. Ann N Y Acad Sci (2006) 1.62
Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury. J Neurotrauma (2004) 1.59
Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J Neurotrauma (2007) 1.58
Bilateral hippocampal volume reduction in adults with post-traumatic stress disorder: a meta-analysis of structural MRI studies. Hippocampus (2005) 1.58
Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. J Clin Immunol (1988) 1.56
Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock (2007) 1.55
High level of extracellular potassium and its correlates after severe head injury: relationship to high intracranial pressure. J Neurosurg (2000) 1.54
Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. J Neuroimmunol (1997) 1.49
Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J Trauma (2004) 1.46
Evolving trends in the care of polytrauma patients. Injury (2005) 1.46
Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma (2004) 1.46
Understanding combat casualty care statistics. J Trauma (2006) 1.46
Delayed, selective neuronal death following experimental cortical impact injury in rats: possible role in memory deficits. Brain Res (1996) 1.43
Protein accumulation in traumatic brain injury. Neuromolecular Med (2003) 1.41
A meta-analytic examination of basal cardiovascular activity in posttraumatic stress disorder. Psychosom Med (2001) 1.40
Serum neuron-specific enolase as a predictor of intracranial lesions in children with head trauma: a pilot study. Acad Emerg Med (2000) 1.40
IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol (1999) 1.39
Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr Opin Crit Care (2008) 1.34
On linear combinations of biomarkers to improve diagnostic accuracy. Stat Med (2005) 1.34
Guidelines for the management of severe traumatic brain injury. XIII. Antiseizure prophylaxis. J Neurotrauma (2007) 1.34
Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia. J Neurotrauma (2007) 1.34
Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury. J Neuropathol Exp Neurol (1999) 1.33
Peroxynitrite-mediated oxidative damage to brain mitochondria: Protective effects of peroxynitrite scavengers. J Neurosci Res (2007) 1.33
The timing of fracture treatment in polytrauma patients: relevance of damage control orthopedic surgery. Am J Surg (2002) 1.33
Circulating catecholamines and sympathetic activity after head injury. Neurosurgery (1981) 1.32
Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir (Wien) (1998) 1.32
Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Arch Neurol (2003) 1.31
Changes in blood-brain barrier permeability to large and small molecules following traumatic brain injury in mice. Eur J Neurosci (2007) 1.27
Clinical applications of proteomics: proteomic pattern diagnostics. J Mammary Gland Biol Neoplasia (2002) 1.26
Epilepsy after head injury: an overview. Epilepsia (2009) 1.25
Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma (2007) 1.24
Biochemical, cellular, and molecular mechanisms in the evolution of secondary damage after severe traumatic brain injury in infants and children: Lessons learned from the bedside. Pediatr Crit Care Med (2000) 1.23
A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. J Neurotrauma (2004) 1.22
C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res (2002) 1.21
Cytokines and brain injury: invited review. J Intensive Care Med (2008) 1.21
Post-traumatic epilepsy: an overview. Clin Neurol Neurosurg (2005) 1.20
Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. J Neurol Sci (2005) 1.20
Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain (2003) 1.20
Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. Biochem J (2006) 1.18
Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin Chem (1999) 1.17
Clinical correlates of DHEA associated with post-traumatic stress disorder. Acta Psychiatr Scand (2006) 1.17
Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage. Acta Neurochir (Wien) (1992) 1.17
Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. J Trauma (2003) 1.17
S100B serum level predicts computed tomography findings after minor head injury. J Trauma (2007) 1.17
Interleukin 1beta and interleukin 6 relationship with paediatric head trauma severity and outcome. Childs Nerv Syst (2004) 1.16
Military traumatic brain and spinal column injury: a 5-year study of the impact blast and other military grade weaponry on the central nervous system. J Trauma (2009) 1.15
An increased capacity for adrenal DHEA release is associated with decreased avoidance and negative mood symptoms in women with PTSD. Neuropsychopharmacology (2004) 1.15
Elevation of tumor necrosis factor in head injury. J Neuroimmunol (1990) 1.15
Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure. J Neurotrauma (2008) 1.14
A prospective study of heart rate response following trauma and the subsequent development of posttraumatic stress disorder. Arch Gen Psychiatry (1998) 1.14
Proteomic identification of biomarkers of traumatic brain injury. Expert Rev Proteomics (2005) 1.14
Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit Care Med (2003) 1.13
Adding insult to injury: the prognostic value of early secondary insults for survival after traumatic brain injury. J Neurol Neurosurg Psychiatry (1999) 1.13
Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia. J Neurotrauma (2004) 1.13
Neuron-specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg (1996) 1.13
F2-isoprostane and neuron-specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children. J Neurotrauma (2003) 1.11
The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury. J Neurotrauma (2008) 1.11
Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injury. J Neurotrauma (2008) 1.11
Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry (2001) 1.10
Role of intracranial pressure values and patterns in predicting outcome in traumatic brain injury: a systematic review. Neurocrit Care (2007) 1.09
Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients. J Neurotrauma (2004) 1.07
Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool. Pediatrics (2006) 1.07
Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury. Brain Inj (2006) 1.06
Apoptotic morphology of dentate gyrus granule cells following experimental cortical impact injury in rats: possible role in spatial memory deficits. Brain Res (1996) 1.06
Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J Neurotrauma (2002) 1.06
The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj (2000) 1.06
Endogenous melatonin increases in cerebrospinal fluid of patients after severe traumatic brain injury and correlates with oxidative stress and metabolic disarray. J Cereb Blood Flow Metab (2008) 1.06
Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res (1996) 1.06
The diploid genome sequence of an Asian individual. Nature (2008) 46.29
The sequence and de novo assembly of the giant panda genome. Nature (2009) 15.76
Biosensing with plasmonic nanosensors. Nat Mater (2008) 12.10
The genome of the cucumber, Cucumis sativus L. Nat Genet (2009) 8.19
Ancient human genome sequence of an extinct Palaeo-Eskimo. Nature (2010) 7.51
Raltegravir with optimized background therapy for resistant HIV-1 infection. N Engl J Med (2008) 7.33
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection. N Engl J Med (2008) 5.58
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals. J Acquir Immune Defic Syndr (2006) 4.71
The cell and molecular basis of mechanical, cold, and inflammatory pain. Science (2008) 3.46
Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation (2005) 3.28
A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study. Ophthalmology (2012) 3.24
Activation of p53 by MEG3 non-coding RNA. J Biol Chem (2007) 3.07
Complete resequencing of 40 genomes reveals domestication events and genes in silkworm (Bombyx). Science (2009) 2.68
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial. Lancet Infect Dis (2011) 2.66
A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation. Nat Immunol (2013) 2.60
Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses. J Acquir Immune Defic Syndr (2010) 2.37
CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain. Proc Natl Acad Sci U S A (2008) 2.36
Genetic variation in SCN10A influences cardiac conduction. Nat Genet (2010) 2.30
Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer. Clin Cancer Res (2013) 2.28
Synthesis, molecular modeling, and biological evaluation of cinnamic acid metronidazole ester derivatives as novel anticancer agents. Bioorg Med Chem (2010) 2.25
Activation of the indole-3-acetic acid-amido synthetase GH3-8 suppresses expansin expression and promotes salicylate- and jasmonate-independent basal immunity in rice. Plant Cell (2008) 2.19
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials. Clin Infect Dis (2010) 2.14
Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry. Clin Chem (2005) 2.13
H2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun (2004) 2.11
Dispersive pad site burns with modern radiofrequency ablation equipment. Surg Laparosc Endosc Percutan Tech (2003) 2.09
c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology (2014) 2.04
An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice. Neuron (2011) 2.00
Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun (2004) 1.98
A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal. Liver Int (2013) 1.97
A novel copper complex of salicylaldehyde pyrazole hydrazone induces apoptosis through up-regulating integrin beta4 in H322 lung carcinoma cells. Eur J Med Chem (2010) 1.94
Coupling of cell migration with neurogenesis by proneural bHLH factors. Proc Natl Acad Sci U S A (2006) 1.87
MicroRNA-204/211 alters epithelial physiology. FASEB J (2010) 1.83
Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci (2007) 1.82
Controlled plasmonic nanostructures for surface-enhanced spectroscopy and sensing. Acc Chem Res (2008) 1.79
Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK. Clin Infect Dis (2011) 1.77
Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation. Crit Care Med (2008) 1.74
Generation of genetically modified mice by oocyte injection of androgenetic haploid embryonic stem cells. Cell (2012) 1.72
Compact high-quality CdSe-CdS core-shell nanocrystals with narrow emission linewidths and suppressed blinking. Nat Mater (2013) 1.71
Human traumatic brain injury alters plasma microRNA levels. J Neurotrauma (2010) 1.70
A role for prefrontal cortex in memory storage for trace fear conditioning. J Neurosci (2004) 1.69
Diagnostic performance of urea breath test, rapid urea test, and histology for Helicobacter pylori infection in patients with partial gastrectomy: a meta-analysis. J Clin Gastroenterol (2012) 1.61
Spatial memory formation and memory-enhancing effect of glucose involves activation of the tuberous sclerosis complex-Mammalian target of rapamycin pathway. J Neurosci (2006) 1.59
Hyphal growth patterns and recurrence of fungal keratitis after lamellar keratoplasty. Ophthalmology (2007) 1.54
Feasibility study of cytokine removal by hemoadsorption in brain-dead humans. Crit Care Med (2008) 1.53
Selective fluorescent probes for live-cell monitoring of sulphide. Nat Commun (2011) 1.51
Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy. Am J Surg (2010) 1.51
Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc Natl Acad Sci U S A (2007) 1.49
Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation. J Am Coll Surg (2010) 1.47
Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases. Cancer (2010) 1.46
Ultrastable substrates for surface-enhanced Raman spectroscopy: Al2O3 overlayers fabricated by atomic layer deposition yield improved anthrax biomarker detection. J Am Chem Soc (2006) 1.46
Early warning of cotton bollworm resistance associated with intensive planting of Bt cotton in China. PLoS One (2011) 1.46
A survivin double point mutant has potent inhibitory effect on the growth of hepatocellular cancer cells. Cancer Biol Ther (2008) 1.45
Heat shock protein 70 silencing enhances apoptosis inducing factor-mediated cell death in hepatocellular carcinoma HepG2 cells. Cancer Biol Ther (2009) 1.44
Stable knockdown of estrogen receptor alpha by vector-based RNA interference suppresses proliferation and enhances apoptosis in breast cancer cells. Cancer Biol Ther (2006) 1.44
Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling. Stem Cells Dev (2010) 1.44
Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin. Mol Pharmacol (2008) 1.43
CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat (2011) 1.43
A cross-sectional survey of participation of asthmatic children in physical activity. World J Pediatr (2010) 1.43
Depression recognition using resting-state and event-related fMRI signals. Magn Reson Imaging (2012) 1.41
MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin. Biochem Biophys Res Commun (2012) 1.40
Noncompaction cardiomyopathy associated with hypogenetic lung. Chin Med J (Engl) (2007) 1.39
In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection. J Appl Toxicol (2009) 1.38
Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients. Respiration (2012) 1.38
Sulforaphane enhances aquaporin-4 expression and decreases cerebral edema following traumatic brain injury. J Neurosci Res (2005) 1.36
Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS One (2010) 1.36
Pharmacokinetics and pharmacodynamics of once-daily versus twice-daily raltegravir in treatment-naive HIV-infected patients. Antimicrob Agents Chemother (2012) 1.36
MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis. Med Sci Monit (2012) 1.35
Mammalian tissues defective in nonsense-mediated mRNA decay display highly aberrant splicing patterns. Genome Biol (2012) 1.34
The expression pattern of a rice disease resistance gene xa3/xa26 is differentially regulated by the genetic backgrounds and developmental stages that influence its function. Genetics (2007) 1.33
High-density microarray analysis of hippocampal gene expression following experimental brain injury. J Neurosci Res (2002) 1.32
Identification of reference genes for reverse transcription quantitative real-time PCR normalization in pepper (Capsicum annuum L.). Biochem Biophys Res Commun (2011) 1.31
The bHLH transcription factor MdbHLH3 promotes anthocyanin accumulation and fruit colouration in response to low temperature in apples. Plant Cell Environ (2012) 1.30
Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets. Int J Cancer (2011) 1.29
Screening of type I and II drug binding to human cytochrome P450-3A4 in nanodiscs by localized surface plasmon resonance spectroscopy. Anal Chem (2009) 1.28
High genome heterozygosity and endemic genetic recombination in the wheat stripe rust fungus. Nat Commun (2013) 1.28
Diverse genetic basis of field-evolved resistance to Bt cotton in cotton bollworm from China. Proc Natl Acad Sci U S A (2012) 1.28
A soybean β-expansin gene GmEXPB2 intrinsically involved in root system architecture responses to abiotic stresses. Plant J (2011) 1.25
Detection of the TCDD binding-fingerprint within the Ah receptor ligand binding domain by structurally driven mutagenesis and functional analysis. Biochemistry (2009) 1.23
Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids (2007) 1.23
Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function. Mol Biol Cell (2010) 1.23
Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation (2010) 1.23
MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin. FEBS Lett (2012) 1.22
Biomarkers for the diagnosis and prognosis of mild traumatic brain injury/concussion. J Neurotrauma (2013) 1.22
Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF-kappaB pathways. J Neuroimmunol (2006) 1.22
Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J (2006) 1.22
HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Gastroenterology (2011) 1.22
Multiple death pathways in TNF-treated fibroblasts: RIP3- and RIP1-dependent and independent routes. Cell Res (2011) 1.20
MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1. J Biomed Sci (2013) 1.18
Physicians' attitudes and practice toward treating injection drug users with hepatitis C: results from a national specialist survey in Canada. Can J Gastroenterol (2011) 1.18
Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study. J Acquir Immune Defic Syndr (2010) 1.17
A role for prefrontal calcium-sensitive protein phosphatase and kinase activities in working memory. Learn Mem (2005) 1.17
Therapeutic effects of ghrelin on endotoxic shock in rats. Eur J Pharmacol (2003) 1.17
TRPC3 and TRPC6 are essential for normal mechanotransduction in subsets of sensory neurons and cochlear hair cells. Open Biol (2012) 1.16
Hydrogen sulfide derived from periadventitial adipose tissue is a vasodilator. J Hypertens (2009) 1.15
Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure. J Neurotrauma (2008) 1.14
Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med (2012) 1.14
Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection. Am J Physiol Renal Physiol (2010) 1.13
Altered expression of miRNA-21 and its targets in the hippocampus after traumatic brain injury. J Neurosci Res (2010) 1.12